It is suitable for the crystal form of 6- [2- (methyl-carbamyl) phenylsulfartyl] -3-E- [2- (pyridine -2- base) vinyl] indazole for the treatment of mammalian abnormal cell growth
The present invention relates to the crystalline polymorphs of 6- [2- (methylcarbamoyl) phenylsulfartyl] -3-E- [2- (pyridine -2- base) vinyl] indazole and amorphous forms with and preparation method thereof. The present invention is also related to the treatment or prevention purposes containing at least one polymorphous pharmaceutical composition and the polymorphic and composition.本發明涉及6-[2-(甲基氨甲酰基)苯基硫基]-3-E-[2-(吡啶-2-基)乙烯基]吲唑的結晶多晶型及非晶形形式以及其製備方法。本發明亦涉及含有至少一種多晶型的藥物組合物以及該多晶型及組合物的治療或預防用途。
